I am a postdoctoral researcher (July 1, 2023–present) in the Department of Biochemistry, Microbiology, and Immunology at the University of Saskatchewan (USask), working in Dr. Oleg Dmitriev’s lab. My research centers on characterizing MEMO1, an iron-binding protein implicated in cancer progression, by exploring its synthetic dosage lethality (SDL) interactions to identify targeted therapies for metastatic cancer. This work includes genome-wide SDL profiling, drug screening, and validation in cell lines. I earned my Ph.D. in Molecular Medicine from Hamadan University of Medical Sciences in Iran, where I investigated miRNA-mediated gene regulation in platinum-based drug-resistant cell lines.
I am a postdoctoral researcher (July 1, 2023–present) in the Department of Biochemistry, Microbiology, and Immunology at the University of Saskatchewan (USask), working in Dr. Oleg Dmitriev’s lab. My research centers on characterizing MEMO1, an iron-binding protein implicated in cancer progression, by exploring its synthetic dosage lethality (SDL) interactions to identify targeted therapies for metastatic cancer. This work includes genome-wide SDL profiling, drug screening, and validation in cell lines. I earned my Ph.D. in Molecular Medicine from Hamadan University of Medical Sciences in Iran, where I investigated miRNA-mediated gene regulation in platinum-based drug-resistant cell lines.